Takeda Pharmaceutical Co. Ltd. has already said that it sees gastroenterology and gastrointestinal therapies as core interests for its commercial and research portfolio, and the top Japanese pharma firm's latest collaboration bears out this focus.
Takeda has just signed a partnership with the privately held venture Cour Pharmaceutical Development Company to research and develop Cour's...